HealthLeap Partners with Houston Methodist for Systemwide Deployment of AI Nutrition Risk Platform

HealthLeap, a leading AI clinical screening startup, led by Josiah Meyer and Jemima Meyer, RD(SA), announced it has launched its AI-driven clinical screening platform across Houston Methodist’s system to help address this issue earlier and more consistently among at-risk inpatients.

HealthLeap is the first and only validated AI-powered malnutrition screening tool with an EHR-integrated screening layer for hospitals. Developed by clinicians for clinicians, the platform continuously analyzes patient records to identify at-risk individuals and delivers actionable risk scores directly within EHR workflows, enabling earlier intervention and improved patient outcomes.

The Hidden Challenge of Nutrition Risk in Hospitals.

Identifying patients at risk for inadequate nutrition remains a significant challenge across hospital systems. While only about 9% of hospitalized patients are formally diagnosed with nutrition-related conditions, an estimated 30% to 50% may be at risk. Missed cases can delay intervention, prolong hospital stays, slow recovery, and increase pressure on healthcare systems, making early identification essential for improving patient outcomes.

Strengthening Early Nutrition Screening Through Clinical Workflows.

Michelle Stansbury said the organization is focused on improving how patients who may benefit from additional nutrition support are identified. Integrating advanced screening tools into clinical workflows enables care teams to recognize nutrition risk earlier, intervene sooner, and support more timely patient recovery.

Enhancing Nutrition Screening With AI.

Traditional nutrition screening often relies on manual assessments and admission-day questionnaires, making it difficult to detect changes in patient risk over time. HealthLeap integrates AI-driven screening into existing clinical workflows, continuously analyzing patient data to identify at-risk individuals and prioritize those requiring urgent attention. Earlier identification enables care teams to intervene sooner, improve patient outcomes, and support more efficient care delivery.

Continuous AI Screening Across the Patient Journey.

HealthLeap's validated AI platform screens all inpatients daily from admission through discharge, providing continuous visibility into nutrition risk. Ongoing monitoring enables earlier intervention, helps reduce complications and avoidable delays, supports shorter hospital stays, and improves documentation for a more accurate assessment of patient severity.

Supporting Proactive Patient Care.

Josiah Meyer said the collaboration with Houston Methodist reflects a shared commitment to advancing earlier patient risk identification and strengthening proactive, data-driven care.

Measuring Clinical and Operational Impact.

HealthLeap and Houston Methodist will evaluate the impact of the initiative across clinical, operational, and financial metrics, including hospital length of stay and the consistency of identifying and documenting patients who may benefit from nutrition-related care.